| scholarly article | Q13442814 |
| P2093 | author name string | Daniel Scherman | |
| Anne Galy | |||
| Christian Jorgensen | |||
| Florence Apparailly | |||
| Gabriel Courties | |||
| Maroun Khoury | |||
| Céline Largeau | |||
| Virginie Escriou | |||
| Roseline Yao | |||
| P2860 | cites work | RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells | Q42445726 |
| P433 | issue | 8 | |
| P304 | page(s) | 2356-2367 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes | |
| P478 | volume | 58 |
| Q53266970 | ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis. |
| Q34413235 | Active immunization to tumor necrosis factor-alpha is effective in treating chronic established inflammatory disease: a long-term study in a transgenic model of arthritis |
| Q40324590 | Adenovirus-Mediated Small Interfering RNA Targeting TAK1 Ameliorates Joint Inflammation with Collagen-Induced Arthritis in Mice |
| Q35285800 | Alternative for anti-TNF antibodies for arthritis treatment |
| Q36245722 | Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators? |
| Q47429306 | Dendrimers: Breaking the paradigm of current musculoskeletal autoimmune therapies |
| Q50268454 | Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases |
| Q39343765 | Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findings |
| Q53014578 | Gene Therapy for Autoimmune Disease. |
| Q37207021 | Gene therapy of the rheumatic diseases: 1998 to 2008. |
| Q39102784 | Genetic pharmacology: progresses in siRNA delivery and therapeutic applications |
| Q33414996 | Glioma angiogenesis: Towards novel RNA therapeutics |
| Q47578379 | Grand challenges in modulating the immune response with RNAi nanomedicines. |
| Q35153715 | Histological study of the biodynamics of iron oxide nanoparticles with different diameters |
| Q34478119 | Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis |
| Q37916426 | Nanotherapeutic approaches for the treatment of rheumatoid arthritis |
| Q45950376 | Nicotinamide phosphoribosyltransferase/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis. |
| Q45881243 | Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation |
| Q41860441 | Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis |
| Q50698107 | Polyethyleneimine-functionalized iron oxide nanoparticles for systemic siRNA delivery in experimental arthritis. |
| Q37453905 | Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis |
| Q37579041 | Progress and Prospects: genetic treatments for disorders of bones and joints |
| Q28255877 | Progress toward in vivo use of siRNAs-II |
| Q38669113 | Recent advances in nanomedicines for the treatment of rheumatoid arthritis |
| Q42266961 | Silencing TNF-α in macrophages and dendritic cells for arthritis treatment |
| Q45861904 | Soluble TNF-α receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer |
| Q35040995 | Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis |
| Q38264691 | Targeted delivery systems for biological therapies of inflammatory diseases |
| Q39212602 | Ternary polymeric nanoparticles for oral siRNA delivery |
| Q28548580 | Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases |
| Q95446216 | siRNA-based therapeutic approaches for rheumatic diseases |
Search more.